Relapsed and Refractory T-cell Lymphoma

Also known as: Relapsed/Refractory T-cell Lymphomas / Refractory and Relapsed T Cell Lymphoma

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB00188	Bortezomib	1	Active Not Recruiting	1
DB11952	Duvelisib	1	Active Not Recruiting	1
DB09053	Ibrutinib	1	Completed	1
DB06176	Romidepsin	1	Active Not Recruiting	1